AIA forces changes in invention capture and review procedures: study

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

AIA forces changes in invention capture and review procedures: study

The America Invents Act has prompted many companies to make changes in their invention capture and review procedures and public disclosure polices, according to a study released by IP advisory firm ipPerformance

Compared to study results released in 2012 before implementation of the AIA, roughly double the companies indicated that they made changes in invention capture and submission stage versus their preparation and filing stage.

Some 85% of companies indicated that the AIA has influenced them to make public disclosure of an invention prior to patent filing policy changes. A third of companies indicated that the increase in USPTO fees will cause an increase to their patent budget.

“America Invents Act has encouraged companies to adapt their procedures, workflows and policies. The increased fees as well as pre and post grant proceedings are major factors that are impacting budgeting and strategy,” said Robert Williamson, president at ipPerformance Group.

Fifty-nine companies representing a variety of industries participated in the study, including Air Liquide, Nova Chemical, Sun Chemical, Dow Corning Corporation, Nova Measuring Instruments, ZBD, Avebe, Sasol, Neste Oil, Micro Encoder, Automotive Technologies and Freescale Semiconductor.

more from across site and SHARED ros bottom lb

More from across our site

Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Susan Keston and Rachel Fetches at HGF explain why the CoA’s decision to grant the UPC’s first permanent injunction demonstrates the court’s readiness to diverge from national court judgments
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Stability AI, represented by Bird & Bird, is not liable for secondary copyright infringement, though Fieldfisher client Getty succeeds in some trademark claims
Gift this article